期刊文献+

胰岛素样生长因子受体Ⅰ序列结构的生物信息学分析 被引量:3

Bioinformatics analysis of sequence and structure of insulin-like growth factor-I receptor
原文传递
导出
摘要 胰岛素样生长因子受体Ⅰ的3'UTR长度大于7 kb,结构复杂,有多种mi RNAs的结合位点,参与信号通路中MAPK及PI3K/AKT的调节和多种肿瘤的形成和发展,通过生物信息学分析知道其结构特点,为后续研究提供思路。分析表明儿童神经胶质瘤中IGF1R的3'UTR与mi RNAs结合位点突变率最高。分析IGF1R序列3'UTR的结构,mi RNAs结合位点,氨基酸序列的理化性质,亲疏水性,糖基化和磷酸化位点,二级结构和三级结构建模。IGF1R三级结构与配体IGF1的三级结构模拟分子对接,得到2种蛋白相互作用的氨基酸位置及名称。因此,通过对IGF1R 3'UTR突变,降低与mi RNAs的结合,IGF1R表达上调,同时改变与IGF1的氨基酸结合位点,降低2种蛋白的相互作用,从而抑制IGF1R的作用。 The length of IGF1 R 3'UTR is greater than 7 kb. The structure of IGF1 R 3'UTR is complex, with multiple binding sites of mi RNAs. IGF1 R is involved in the regulation of MAPK and PI3K/AKT signaling pathways and the formation and development of tumors. Bioinformatics analysis can reveal the structure features of IGF1 R, which provides ideas for further research. The analysis shows that the binding sites between IGF1 R and mi RNAs have the highest mutation rate in Neuroblastoma. We analyzed the structure of 3'UTR, mi RNAs binding sites, physical and chemical properties, hydrophilic-hydrophobic property, glycosylation and phosphorylation sites, secondary structure and tertiary structure modeling of IGF1 R. The locations and names of amino acids interacting in IGF1 R and IGF1 were obtained by molecular docking. Therefore, if IGF1 R 3'UTR is mutated, the capacity of IGF1 R combined with mi RNAs will reduce and the IGF1 R expression will be up-regulated, and the function of mi RNAs will be repressed. We can change the sites of IGF1 R to combine with IGF1 to repress the function of IGF1 R and IGF1. Then the function of IGF1 R will be repressed.
出处 《生物工程学报》 CAS CSCD 北大核心 2016年第5期693-701,共9页 Chinese Journal of Biotechnology
基金 教育部留学回国人员科研启动基金(No.2013S03008) 国家自然科学基金(No.31500276)资助~~
关键词 胰岛素样生长因子受体I 序列分析 三维建模 分子对接 insulin-like growth factor-I receptor(IGF1R) sequence analysis 3D-struture modeling molecular docking
  • 相关文献

参考文献19

  • 1Zhou Q, Zhang JX, Cui QY, et al. GSK1904529A, an insulin-like growth factor-1 receptor inhibitor, inhibits glioma tumor growth, induces apoptosis and inhibits migration. Mol Med Rep, 2015, 12(3): 3381-3385, doi: 10.3892/mmr.2015.3869.
  • 2Huang H, Chen Q, Ku X, et al. A series of a-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIa catalytic activity. J Med Chem, 2010, 53(8): 3048-3064.
  • 3Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs, eLife, 2015, 4: e05005.
  • 4Madhusudhan MS, Marti-Renom MA, Eswar N, et al. Comparative protein structure modeling//Walker JM, ed. The Proteomics Protocols Handbook. Totowa, New Jersey: Humana Press, 2005: 831-860.
  • 5Gupta R, Jung E, Brunak S. Predicition of N-glycosylation Sites in Human Proteins. New Jersey: Wiley, 2005: 163-192.
  • 6Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol, 1999, 294(5): 1351-1362.
  • 7Geourjon C, Del6age G. SOPMA: significantimprovements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci, 1995, 11(6): 681-684.
  • 8Schwede T, Kopp J, Guex N, et al. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res, 2003, 31(13): 3381-3385.
  • 9Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J Comput Chem, 2010, 31(2): 455461.
  • 10刘宝英,聂尚海,杜清友,刘农乐,赵强,柳川,王会信.重组人胰岛素样生长因子1的促糖代谢作用研究[J].中国糖尿病杂志,1999,7(4):195-197. 被引量:5

二级参考文献18

  • 1刘宝英,赵明,王会信,丁红梅,王芳,赵强.人胰岛素样生长因子 Ⅰ 基因的人工半合成和克隆[J].军事医学科学院院刊,1997,21(1):20-23. 被引量:5
  • 2Yu H,Spitz MR,Mistry J,et al.Plasma levels of insulin-like growth factor-I and lung cancer risk:a case-control analysis [J].J Natl Cancer Inst,1999,91(2):151-156.
  • 3Valentinis B,Baserga R.IGF-I receptor signalling in transformation and differentiation [J].Mol Pathol,2001,54(3):133-137.
  • 4Pavelic J,Krizanac S,Kapitanovic S,et al.The consequences of insulin-like growth factors/receptors dysfunction in lung cancer [J].Am J Respir Cell Mol Biol,2005,32(1):65-71.
  • 5Brognard J,Clark AS,Ni Y,et al.PKB/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation [J].Cancer Res,2001,61(4):3986-3997.
  • 6Chun K,Kosmeder II JW,Sun S,et al.Effects of deguelin on the phosphatidylinositol 3-kinase/AKT pathway and apoptosis in premalignant human bronchial epithelial cells [J].J Natl Cancer Inst,2003,95(4):291-302.
  • 7Balsara BR,Pei J,Mitsuuchi Y,et al.Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions [J].Carcino-genesis,2004,25(11):2053-2059.
  • 8Quinn KA,Treston AM,Unsworth EJ,et al.Insulin-like growth factor expression in human cancer cell lines [J].J Biol Chem,1996,271(19):11477-11483.
  • 9Furstenberger G,Senn HJ.Insulin-like growth factors and cancer [J].Lancet Oncol,2002,3(5):298-302.
  • 10Moorehead RA,Sanchez OH,Baldwin RM,et al.Transgenic overexpression of IGF-II induces spontaneous lung tumors:a model for human lung adenocarcinoma [J].Oncogene,2003,22(6):853-857.

共引文献20

同被引文献26

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部